Adjuvatis

Adjuvatis is a private, pre-revenue biotech platform company specializing in innovative, safe-by-design nanoparticle delivery systems. Its proprietary i-Particles® (biodegradable polymer particles) and i-LipoP® (lipid-bilayer coated particles for nucleic acid delivery) technologies aim to overcome formulation challenges in vaccines, drug delivery, and diagnostics. The company leverages a collaborative model, offering analytical services and custom formulations to partners while positioning itself in the growing markets for advanced vaccine adjuvants and mRNA delivery solutions.

i-Particles®: Biodegradable, surfactant-free polymer particles for API delivery. i-LipoP®: i-Particles® core coated with a lipidic bilayer for nucleic acid (e.g., mRNA) vectorization.

Adjuvatis competes in the crowded drug delivery and vaccine adjuvant space against large chemical companies (e.g., Croda, Merck) and numerous biotech startups. In mRNA delivery, it must differentiate i-LipoP® from dominant LNP technologies held by companies like Acuitas Therapeutics and Genevant Sciences.